Zhou et al. reported that polygenetic variants at the 11q23 locus, including APOA5 rs662799, are linked to an increased 3GO risk of a condition called co-occurring hypertension, hyperglycemia, and dyslipidemia, which is composed of MetS [61]. This evidence concerns the gene APOA5 and metabolic syndrome.